The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Objective: Primary objective of the present study was to assess the relative bioavailability of Alfuzosin 10 mg Prolong-released Tablets under Fed conditions, in Healthy Thai Male Volunteers after an oral administration with 7 days washout period. Study Design: A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study
Epistemonikos ID: 05929b4f8d059f5dd13430e532864294713af4ff
First added on: May 15, 2024